Literature DB >> 2113177

Transcription analysis of class II human leukocyte antigen genes from normal and immunodeficient B lymphocytes, using polymerase chain reaction.

M Bull1, A van Hoef, J Gorski.   

Abstract

The RNA transcript levels of all human leukocyte antigen class II loci were determined from class II congenital immunodeficient B cells by polymerase chain reaction amplification of cDNA. No mRNA was observed under conditions in which 0.01% normal levels could be visualized. Pre-mRNA could be amplified from normal B cells but not from immunodeficient B cells, indicating a transcription defect.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2113177      PMCID： PMC360836          DOI： 10.1128/mcb.10.7.3792-3796.1990

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN： 0270-7306            Impact factor:   4.272


  32 in total

1.  Simultaneous isolation of preparative amounts of RNA and DNA from Trichinella spiralis by cesium trifluoroacetate isopycnic centrifugation.

Authors:  D S Zarlenga; H R Gamble
Journal:  Anal Biochem       Date:  1987-05-01       Impact factor: 3.365

2.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

3.  Characterization of the cDNA encoding a protein binding to the major histocompatibility complex class II Y box.

Authors:  D K Didier; J Schiffenbauer; S L Woulfe; M Zacheis; B D Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

4.  Two distinct nuclear factors bind the conserved regulatory sequences of a rabbit major histocompatibility complex class II gene.

Authors:  N Sittisombut
Journal:  Mol Cell Biol       Date:  1988-05       Impact factor: 4.272

5.  Conserved upstream sequences of human class II major histocompatibility genes enhance expression of class II genes in wild-type but not mutant B-cell lines.

Authors:  J H Sloan; J M Boss
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

6.  Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X.

Authors:  W Reith; S Satola; C H Sanchez; I Amaldi; B Lisowska-Grospierre; C Griscelli; M R Hadam; B Mach
Journal:  Cell       Date:  1988-06-17       Impact factor: 41.582

7.  Distinct cloned class II MHC DNA binding proteins recognize the X box transcription element.

Authors:  H C Liou; M R Boothby; L H Glimcher
Journal:  Science       Date:  1988-10-07       Impact factor: 47.728

8.  Compartmentalization of MHC class II gene expression in transgenic mice.

Authors:  W van Ewijk; Y Ron; J Monaco; J Kappler; P Marrack; M Le Meur; P Gerlinger; B Durand; C Benoist; D Mathis
Journal:  Cell       Date:  1988-05-06       Impact factor: 41.582

9.  Regulation of genes for HLA class II antigens in cell lines from patients with severe combined immunodeficiency.

Authors:  C de Préval; M R Hadam; B Mach
Journal:  N Engl J Med       Date:  1988-05-19       Impact factor: 91.245

10.  Two distinct genetic loci regulating class II gene expression are defective in human mutant and patient cell lines.

Authors:  Z Yang; R S Accolla; D Pious; B J Zegers; J L Strominger
Journal:  EMBO J       Date:  1988-07       Impact factor: 11.598
View more
  9 in total

1.  A cDNA clone for a novel nuclear protein with DNA binding activity.

Authors:  T Mattioni; C R Hume; S Konigorski; P Hayes; Z Osterweil; J S Lee
Journal:  Chromosoma       Date:  1992-10       Impact factor: 4.316

Review 2.  The polymerase chain reaction and other amplification techniques in immunological research and diagnosis.

Authors:  A M Lew; R B Brandon; M Panaccio; C J Morrow
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

3.  Deficient antigen-presenting cell function in multiple genetic complementation groups of type II bare lymphocyte syndrome.

Authors:  S Kovats; G T Nepom; M Coleman; B Nepom; W W Kwok; J S Blum
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

4.  Definition of a novel complementation group in MHC class II deficiency.

Authors:  A Peijnenburg; B Godthelp; A van Boxel-Dezaire; P J van den Elsen
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

5.  Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes.

Authors:  Q Li; M K Spriggs; S Kovats; S M Turk; M R Comeau; B Nepom; L M Hutt-Fletcher
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

6.  HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance.

Authors:  P Paul; N Rouas-Freiss; I Khalil-Daher; P Moreau; B Riteau; F A Le Gal; M F Avril; J Dausset; J G Guillet; E D Carosella
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

7.  Physiologic target of the Air-1 trans-activator revealed by stable transfection assay.

Authors:  S Sartoris; A De Lerma Barbaro; T Cestari; G Tridente; R S Accolla
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

8.  Functional complementation of major histocompatibility complex class II regulatory mutants by the purified X-box-binding protein RFX.

Authors:  B Durand; M Kobr; W Reith; B Mach
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

9.  A functionally essential domain of RFX5 mediates activation of major histocompatibility complex class II promoters by promoting cooperative binding between RFX and NF-Y.

Authors:  J Villard; M Peretti; K Masternak; E Barras; G Caretti; R Mantovani; W Reith
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.